Dayan Udi Yehuda sold $100 of NICE

Dayan Udi Yehuda (VP, Corporate Finance) sold 500 shares of NICE Ltd. (NICE) at $0.20 on 2026-08-07.

Original reporting
SEC EDGAR · Dayan Udi Yehuda
Published Aug 10, 2026, 4:59 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 10, 2026, 5:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$NICE
Neutral
low confidence
Mentioned
$NICE
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$NICENeutralLow
01

Why it matters

The newest fact is the specific sale details: 500 shares sold at $0.20/share on 2026-08-07, with holdings after the transaction at 0 shares.

02

Market read

A routine, small insider sale is disclosed via SEC EDGAR, with limited expected impact on trading decisions.

03

What to watch

The filing does not indicate intent beyond the sale code and does not provide context like diversification, tax planning, or prior grants.

Relevance 3/10Novelty 2/10Timing: filed 2026-08-10, after-hours/late-day SEC disclosure

Background

The article is an SEC Form 4 insider transaction disclosure for NICE Ltd., reported by VP, Corporate Finance Dayan Udi Yehuda.

Company-level read

Ticker impact

$NICENeutralLow confidence
Context

SEC Form 4 shows NICE insider Dayan Udi Yehuda sold 500 shares at $0.20/share on 2026-08-07, leaving 0 shares.

Expected impact

Low likelihood of a near-term price reaction; any impact is more about sentiment than fundamentals.

Evidence & confidence

Form 4 insider sales are common and this transaction is small ($100) relative to typical market-moving thresholds, with no accompanying corporate event or guidance change.

Market effects

No sector read-through; this is an individual insider transaction without stated corporate action.

None indicated.

None indicated.

Counterpoint

Even small insider sales can be interpreted as caution, especially without a disclosed 10b5-1 plan, but the $100 scale limits signal strength.

Key entities

  • NICE Ltd.

    Subject of the Form 4 insider transaction disclosure.

  • Dayan Udi Yehuda

    VP, Corporate Finance; sold 500 shares in an open-market sale.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$NICEMed

NiCE Cognigy Adds Reusable Skills, Decision Tracing

NiCE launched an updated AI agent platform with features like reusable skills, decision tracing, and integrations with OpenAI, Anthropic, and others. The company aims to help enterprises scale AI agents across customer journeys. NiCE reported Q3 2026 revenue of $790.7 million and AI ARR of $392 million, maintaining full-year guidance of $3.17–$3.19 billion.

$NICEMedAI 8/10

NICE Ltd (NICE) (Q3 2026) Earnings Call Highlights: AI ARR Jumps 46% as Revenue Tops Guidance

NICE Ltd (NICE) reported Q3 2026 earnings, with AI ARR up 46% and revenue exceeding guidance. Cloud revenue grew 10.6% YoY, but management expressed dissatisfaction. The company plans a 5% workforce reduction, with $15-20M in restructuring charges. Free cash flow margin outlook was lowered to 10-12%. CEO Scott Russell remains confident in cloud growth reacceleration, citing AI and international market growth.

$NICEHighAI 8/10

NICE (NICE) Q3 2026 Earnings Call Transcript

NICE reported Q3 2026 revenue of $791M and non-GAAP EPS of $2.84, exceeding guidance. Cloud revenue grew 10.6% (12.2% excluding a customer credit), with AI ARR up 46% YoY. The company is focusing on accelerating AI adoption and monetization, with Cognigy driving growth. NICE also secured significant deals, including an 8-digit ACV deal with a global telecommunications provider.

$NICEMedAI 8/10

NiCE Q3 Earnings Call Highlights

NiCE reported Q3 AI revenue growth of 46% YoY to $392M, with cloud revenue at 16%. CXone backlog grew 27% YoY. Cloud growth was below expectations, but international revenue rose 33%. Non-GAAP operating margin was 27%. The company maintained its 2026 revenue outlook of $3.17B-$3.19B and raised adjusted EPS guidance to $11.12-$11.32.